| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Ablation and antireflux surgery for regression of Barrett’s oesophagus
|
L englinger, J.
|
|
2007
|
|
3 |
p. 509-510
|
article
|
| 2 |
Ablation and antireflux surgery for regression of Barrett’s oesophagus: authors’ reply
|
F erraris, R.
|
|
2007
|
|
3 |
p. 510-511
|
article
|
| 3 |
A higher diagnostic profile is possible for microscopic colitis
|
C ammarota, G.
|
|
2006
|
|
3 |
p. 561
|
article
|
| 4 |
A higher diagnostic profile is possible for microscopic colitis: authors’ reply
|
N yhlin, N.
|
|
2006
|
|
3 |
p. 562
|
article
|
| 5 |
A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn’s disease
|
MANSFIELD, J. C.
|
|
2007
|
|
3 |
p. 421-430
|
article
|
| 6 |
A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis
|
LEES, C. W.
|
|
2007
|
|
3 |
p. 411-419
|
article
|
| 7 |
Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis
|
DUPONT, A. W.
|
|
2007
|
|
3 |
p. 431-441
|
article
|
| 8 |
Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study)
|
GARRIGUES, V.
|
|
2007
|
|
3 |
p. 323-332
|
article
|
| 9 |
Clinical features of Japanese male patients with type 1 autoimmune hepatitis
|
MIYAKE, Y.
|
|
2006
|
|
3 |
p. 519-523
|
article
|
| 10 |
Coeliac disease and the risk of fractures – a general population-based cohort study
|
LUDVIGSSON, J. F.
|
|
2007
|
|
3 |
p. 273-285
|
article
|
| 11 |
Coexistence between colorectal cancer/adenoma and coronary artery disease: results from 1382 patients
|
CHAN, A. O. O.
|
|
2006
|
|
3 |
p. 535-539
|
article
|
| 12 |
Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B
|
BUTI, M.
|
|
2006
|
|
3 |
p. 409-419
|
article
|
| 13 |
Cost-effectiveness of suppressing hepatitis B virus DNA in immune tolerant patients to prevent hepatocellular carcinoma and cirrhosis
|
ENRIQUEZ, A. D.
|
|
2007
|
|
3 |
p. 383-391
|
article
|
| 14 |
Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa
|
WILLICH, S. N.
|
|
2006
|
|
3 |
p. 371-376
|
article
|
| 15 |
Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial
|
GUYONNET, D.
|
|
2007
|
|
3 |
p. 475-486
|
article
|
| 16 |
Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome
|
KAJANDER, K.
|
|
2007
|
|
3 |
p. 463-473
|
article
|
| 17 |
Eosinophilic oesophagitis and coeliac disease: is there an association?
|
QUAGLIETTA, L.
|
|
2007
|
|
3 |
p. 487-493
|
article
|
| 18 |
Errata
|
|
|
2006
|
|
3 |
p. 449
|
article
|
| 19 |
First-line triple therapy with levofloxacin for Helicobacter pylori eradication
|
GISBERT, J. P.
|
|
2007
|
|
3 |
p. 495-500
|
article
|
| 20 |
Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy
|
QUA, C. S.
|
|
2007
|
|
3 |
p. 287-295
|
article
|
| 21 |
Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease
|
SALMI, T. T.
|
|
2006
|
|
3 |
p. 541-552
|
article
|
| 22 |
Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study
|
BROEKAERT, D.
|
|
2006
|
|
3 |
p. 365-370
|
article
|
| 23 |
Interferon-α therapy in HBeAg-negative chronic hepatitis B: a long-term prospective study from north-western Greece
|
BALTAYIANNIS, G.
|
|
2006
|
|
3 |
p. 525-533
|
article
|
| 24 |
Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms?
|
LEEDS, J. S.
|
|
2007
|
|
3 |
p. 265-271
|
article
|
| 25 |
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection
|
WONG, W. M.
|
|
2006
|
|
3 |
p. 421-427
|
article
|
| 26 |
Letters to the Editors
|
G raham, D. Y.
|
|
2007
|
|
3 |
p. 345-346
|
article
|
| 27 |
Long-term prognosis in Crohn's disease: factors that affect quality of life
|
CANAVAN, C.
|
|
2006
|
|
3 |
p. 377-385
|
article
|
| 28 |
Long-term reversal of hypocholesterolaemia in patients with chronic hepatitis C is related to sustained viral response and viral genotype
|
FERNÁNDEZ-RODRÍGUEZ, C. M.
|
|
2006
|
|
3 |
p. 507-512
|
article
|
| 29 |
Low serum HBV DNA levels and development of hepatocellular carcinoma in patients with chronic hepatitis B: a case–control study
|
FUNG, J.
|
|
2007
|
|
3 |
p. 377-382
|
article
|
| 30 |
Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease
|
FABRIZI, F.
|
|
2006
|
|
3 |
p. 497-506
|
article
|
| 31 |
Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children
|
SZAJEWSKA, H.
|
|
2007
|
|
3 |
p. 257-264
|
article
|
| 32 |
Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori
|
FISCHBACH, L.
|
|
2007
|
|
3 |
p. 343-357
|
article
|
| 33 |
Neurokinin-1 receptor antagonism in a human model of visceral hypersensitivity
|
WILLERT, R. P.
|
|
2007
|
|
3 |
p. 309-316
|
article
|
| 34 |
Novel endoscopic observation in Barrett’s oesophagus using high resolution magnification endoscopy and narrow band imaging
|
ANAGNOSTOPOULOS, G. K.
|
|
2007
|
|
3 |
p. 501-507
|
article
|
| 35 |
Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome
|
RUBENSTEIN, J. H.
|
|
2007
|
|
3 |
p. 443-452
|
article
|
| 36 |
Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population
|
JUNG, H.-K.
|
|
2007
|
|
3 |
p. 453-461
|
article
|
| 37 |
Perioperative acute upper gastrointestinal haemorrhage in older patients with hip fracture: incidence, risk factors and prevention
|
FISHER, L.
|
|
2007
|
|
3 |
p. 297-308
|
article
|
| 38 |
Personal view: crystalloid transfusion in acute gastrointestinal haemorrhage: is it beneficial? An historical perspective
|
DUGGAN, J. M.
|
|
2006
|
|
3 |
p. 493-496
|
article
|
| 39 |
Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study
|
BRUNO, R.
|
|
2007
|
|
3 |
p. 369-376
|
article
|
| 40 |
Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease
|
DILGER, K.
|
|
2006
|
|
3 |
p. 387-396
|
article
|
| 41 |
Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt
|
EVERSON, G. T.
|
|
2007
|
|
3 |
p. 401-410
|
article
|
| 42 |
Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization
|
SHEN, H.
|
|
2007
|
|
3 |
p. 393-400
|
article
|
| 43 |
Pre-endoscopic PPI therapy reduces recurrent adverse outcomes in acute non-variceal upper gastrointestinal bleeding
|
Lin, H.-J.
|
|
2007
|
|
3 |
p. 343-344
|
article
|
| 44 |
Pre-endoscopic PPI therapy reduces recurrent adverse outcomes in acute non-variceal upper gastrointestinal bleeding: authors' reply
|
T argownik, L. E.
|
|
2007
|
|
3 |
p. 344-345
|
article
|
| 45 |
Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction
|
DE FRANCESCO, V.
|
|
2006
|
|
3 |
p. 429-435
|
article
|
| 46 |
Relationship between the Fibrotest and portal hypertension in patients with liver disease
|
THABUT, D.
|
|
2007
|
|
3 |
p. 359-368
|
article
|
| 47 |
Review article: appropriate use of corticosteroids in Crohn’s disease
|
IRVING, P. M.
|
|
2007
|
|
3 |
p. 313-329
|
article
|
| 48 |
Review article: biological activity markers in inflammatory bowel disease
|
DESAI, D.
|
|
2007
|
|
3 |
p. 247-255
|
article
|
| 49 |
Review article: complementary and alternative therapies for inflammatory bowel disease
|
LANGMEAD, L.
|
|
2006
|
|
3 |
p. 341-349
|
article
|
| 50 |
Review article: current and emerging therapies for functional dyspepsia
|
SAAD, R. J.
|
|
2006
|
|
3 |
p. 475-492
|
article
|
| 51 |
Review article: evolutionary advances in the delivery of aminosalicylates for the treatment of ulcerative colitis
|
COHEN, R. D.
|
|
2006
|
|
3 |
p. 465-474
|
article
|
| 52 |
Review article: management of hepatic disease following haematopoietic cell transplant
|
McDONALD, G. B.
|
|
2006
|
|
3 |
p. 441-452
|
article
|
| 53 |
Review article: medical management of the liver transplant recipient – a primer for non-transplant doctors
|
SETHI, A.
|
|
2007
|
|
3 |
p. 229-245
|
article
|
| 54 |
Review article: non-biological liver support in liver failure
|
LALEMAN, W.
|
|
2006
|
|
3 |
p. 351-363
|
article
|
| 55 |
Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics
|
CHOLONGITAS, E.
|
|
2006
|
|
3 |
p. 453-464
|
article
|
| 56 |
Review article: the genetic basis of haemochromatosis
|
GRIFFITHS, W. J. H.
|
|
2007
|
|
3 |
p. 331-342
|
article
|
| 57 |
Risk of low-dose aspirin: emphasis on outliers undermines the credibility of the conclusions: author's reply
|
L aine, L.
|
|
2007
|
|
3 |
p. 346-347
|
article
|
| 58 |
Serum levels of soluble CD163 correlate with the inflammatory process in coeliac disease
|
DALY, A.
|
|
2006
|
|
3 |
p. 553-559
|
article
|
| 59 |
Thalidomide: an effective anabolic agent in gastrointestinal cancer cachexia
|
W ilkes, E. A.
|
|
2006
|
|
3 |
p. 445-446
|
article
|
| 60 |
Thalidomide: an effective anabolic agent in gastrointestinal cancer cachexia: authors’ reply
|
O ckenga, J.
|
|
2006
|
|
3 |
p. 446-447
|
article
|
| 61 |
The quantitative validation of non-endoscopic disease activity indices in ulcerative colitis
|
HIGGINS, P. D. R.
|
|
2007
|
|
3 |
p. 333-342
|
article
|
| 62 |
The relationship between dosing of alosetron and discontinuation patterns reported by patients participating in a follow-up programme
|
TENNIS, P.
|
|
2007
|
|
3 |
p. 317-322
|
article
|
| 63 |
Three-year oral pantoprazole administration is effective for patients with Zollinger–Ellison syndrome and other hypersecretory conditions
|
METZ, D. C.
|
|
2006
|
|
3 |
p. 437-444
|
article
|
| 64 |
Transient elastography: a valid alternative to biopsy in patients with chronic liver disease
|
GÓMEZ-DOMÍNGUEZ, E.
|
|
2006
|
|
3 |
p. 513-518
|
article
|
| 65 |
Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice
|
LEE, S. S.
|
|
2006
|
|
3 |
p. 397-408
|
article
|
Journal description